A new meta-analysis in Journal of the National Comprehensive Cancer Network provides updated evidence that methylphenidate-type psychostimulants—a class of medication that increases dopamine and norepinephrine availability ...
May 14, 2026
0
4
A new study, led by scientists at University College Dublin and the University of Edinburgh, has found that commonly prescribed attention deficit hyperactivity disorder (ADHD) medication in childhood may lower the long-term ...
Mar 25, 2026
0
15
Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and methylphenidate exposure with higher adult overweight/obesity and slightly shorter adult height at ages 20 ...
The use of medications for Attention-Deficit Hyperactivity Disorder (ADHD) has increased substantially across Europe over the past decade, with the steepest rises seen among adults—particularly women—according to a large ...
Jan 25, 2026
0
21
Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the U.K. More children and teenagers than ever are being referred for assessment and support, and families are often facing long waits and ...
Jan 23, 2026
0
9
Not long ago, most people thought of attention deficit hyperactivity disorder, or ADHD, as a childhood condition that would eventually be outgrown. Now it's everywhere.
Nov 24, 2025
0
10
Methylphenidate helps the brain to regulate focus and impulse control. It is the most commonly used medicine for ADHD and is the active substance in Concerta, Ritalin, Medikinet and other medicines. The tablets or capsules ...
Nov 13, 2025
0
13
More than 3,000 Australians were poisoned by medications for attention deficit hyperactivity disorder in 2023, a fourfold increase on the 795 cases recorded in 2014 to 3242 in 2023, new research from the University of Sydney ...
Nov 11, 2025
0
17
Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviors, substance misuse, transport accidents, and criminality, ...
Aug 13, 2025
0
46
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn ...
Jul 3, 2025
0
17
